Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Dale

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|May 18, 2006
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapyMichelle Shayne, Jeffrey Crawford, David C Dale, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 20, 2014
Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health AdministrationLi Wang, Richard Barron, Onur Baser, et al.
Nature Reviews. Disease Primers|June 9, 2017
Severe congenital neutropeniasJulia Skokowa, David C Dale, Ivo P Touw, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|December 19, 2002
Cloning and sequencing of the canine neutrophil elastase cDNALouis J Katen, Andrew G Aprikyan, David C Dale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide studyGary H Lyman, David C Dale, Jonathan Friedberg, et al.
Journal of Pediatric Hematology/Oncology|December 7, 2002
Mutant elastase in pathogenesis of cyclic and severe congenital neutropeniaAndrew A G Aprikyan, W Conrad Liles, Laurence A Boxer, et al.
Current Opinion in Hematology|November 26, 2019
Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International RegistryDavid C Dale, Audrey Anna Bolyard, Laurie A Steele, et al.
The Journal of Pediatrics|June 2, 2006
Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutationsLaurence A Boxer, Steven Stein, Danielle Buckley, et al.
Current Opinion in Hematology|October 26, 2019
Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndromeDavid C Dale, Emily Dick, Merideth Kelley, et al.
Cancer|April 1, 2006
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|May 18, 2006
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapyMichelle Shayne, Jeffrey Crawford, David C Dale, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 20, 2014
Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health AdministrationLi Wang, Richard Barron, Onur Baser, et al.
Nature Reviews. Disease Primers|June 9, 2017
Severe congenital neutropeniasJulia Skokowa, David C Dale, Ivo P Touw, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|December 19, 2002
Cloning and sequencing of the canine neutrophil elastase cDNALouis J Katen, Andrew G Aprikyan, David C Dale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide studyGary H Lyman, David C Dale, Jonathan Friedberg, et al.
Journal of Pediatric Hematology/Oncology|December 7, 2002
Mutant elastase in pathogenesis of cyclic and severe congenital neutropeniaAndrew A G Aprikyan, W Conrad Liles, Laurence A Boxer, et al.
Current Opinion in Hematology|November 26, 2019
Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International RegistryDavid C Dale, Audrey Anna Bolyard, Laurie A Steele, et al.
The Journal of Pediatrics|June 2, 2006
Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutationsLaurence A Boxer, Steven Stein, Danielle Buckley, et al.
Current Opinion in Hematology|October 26, 2019
Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndromeDavid C Dale, Emily Dick, Merideth Kelley, et al.
Cancer|April 1, 2006
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.
Pageof 15